Published in Proc Natl Acad Sci U S A on March 01, 1988
Control site location and transcriptional regulation in Escherichia coli. Microbiol Rev (1991) 8.11
Arac/XylS family of transcriptional regulators. Microbiol Mol Biol Rev (1997) 6.56
Negative regulatory loci coupling flagellin synthesis to flagellar assembly in Salmonella typhimurium. J Bacteriol (1991) 3.19
Variation of half-site organization and DNA looping by AraC protein. EMBO J (1993) 2.83
DNA looping. Microbiol Rev (1992) 2.63
Small-molecule inhibitors specifically targeting type III secretion. Infect Immun (2005) 2.02
Glucocorticoid receptor binds cooperatively to adjacent recognition sites. EMBO J (1989) 1.61
Activation of ara operons by a truncated AraC protein does not require inducer. Proc Natl Acad Sci U S A (1990) 1.57
Organization and regulation of the D-xylose operons in Escherichia coli K-12: XylR acts as a transcriptional activator. J Bacteriol (1997) 1.41
Effect of mutations in the cyclic AMP receptor protein-binding site on araBAD and araC expression. J Bacteriol (1989) 1.11
Studies on the binding of the Escherichia coli MelR transcription activator protein to operator sequences at the MelAB promoter. Biochem J (1992) 1.06
Leafy gall formation is controlled by fasR, an AraC-type regulatory gene in Rhodococcus fascians. J Bacteriol (2000) 0.96
Regulation of the operon encoding ribonucleotide reductase: role of the negative sites in nrd repression. J Bacteriol (1990) 0.96
Genome-scale analyses of Escherichia coli and Salmonella enterica AraC reveal noncanonical targets and an expanded core regulon. J Bacteriol (2013) 0.94
Bidirectional transcription from the human immunoglobulin VH6 gene promoter. Nucleic Acids Res (1994) 0.81
Novel activation of araC expression and a DNA site required for araC autoregulation in Escherichia coli B/r. J Bacteriol (1988) 0.80
Demonstration of a divergent transcript from the bidirectional heavy chain immunoglobulin promoter VH441 in B-cells. Nucleic Acids Res (1991) 0.79
DNA looping-dependent autorepression of LEE1 P1 promoters by Ler in enteropathogenic Escherichia coli (EPEC). Proc Natl Acad Sci U S A (2014) 0.77
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Res (1983) 38.72
Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol (1983) 17.47
Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature (1985) 14.41
Gene regulation by proteins acting nearby and at a distance. Nature (1986) 9.71
Regulation of the regulatory gene for the arabinose pathway, araC. J Mol Biol (1976) 5.97
Enzymatic characterization of 17 L-arabinose negative mutants of Escherichia coli. J Bacteriol (1961) 5.83
Cooperative binding of lambda repressors to sites separated by integral turns of the DNA helix. Cell (1986) 5.81
Promoters, activator proteins, and the mechanism of transcriptional initiation in yeast. Cell (1987) 5.59
An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci U S A (1984) 5.42
The Escherichia coli L-arabinose operon: binding sites of the regulatory proteins and a mechanism of positive and negative regulation. Proc Natl Acad Sci U S A (1980) 4.84
The L-arabinose operon in Escherichia coli B-r: a genetic demonstration of two functional states of the product of a regulator gene. Proc Natl Acad Sci U S A (1969) 4.57
The regulation of transcription initiation in bacteria. Annu Rev Genet (1985) 4.15
lac repressor forms loops with linear DNA carrying two suitably spaced lac operators. EMBO J (1987) 4.02
Mechanism of araC autoregulation and the domains of two overlapping promoters, Pc and PBAD, in the L-arabinose regulatory region of Escherichia coli. Proc Natl Acad Sci U S A (1981) 3.99
The DNA binding domain and bending angle of E. coli CAP protein. Cell (1986) 3.99
Repressor structure and the mechanism of positive control. Cell (1983) 3.82
The DNA loop model for ara repression: AraC protein occupies the proposed loop sites in vivo and repression-negative mutations lie in these same sites. Proc Natl Acad Sci U S A (1986) 3.18
Prophage lambda at unusual chromosomal locations. II. Mutations induced by bacteriophage lambda in Escherichia coli K12. J Mol Biol (1973) 3.09
Regulation of the Escherichia coli L-arabinose operon studied by gel electrophoresis DNA binding assay. J Mol Biol (1984) 2.63
Upstream operators enhance repression of the lac promoter. Science (1986) 2.58
Demonstration of two operator elements in gal: in vitro repressor binding studies. Proc Natl Acad Sci U S A (1984) 2.54
Arabinose-induced binding of AraC protein to araI2 activates the araBAD operon promoter. Proc Natl Acad Sci U S A (1987) 2.43
lac Repressor blocks transcribing RNA polymerase and terminates transcription. Proc Natl Acad Sci U S A (1986) 2.07
Upstream repression and CRP stimulation of the Escherichia coli L-arabinose operon. J Mol Biol (1984) 1.84
Synthetic lac operator mediates repression through lac repressor when introduced upstream and downstream from lac promoter. EMBO J (1986) 1.80
Two operator sites separated by 599 base pairs are required for deoR repression of the deo operon of Escherichia coli. EMBO J (1985) 1.75
DNA sequence of the araC regulatory gene from Escherichia coli B/r. Nucleic Acids Res (1980) 1.62
Specific destruction of the second lac operator decreases repression of the lac operon in Escherichia coli fivefold. J Mol Biol (1987) 1.62
In vivo regulation of the Escherichia coli araC promoter. J Bacteriol (1983) 1.36
Regulation of the operon encoding ribonucleotide reductase in Escherichia coli: evidence for both positive and negative control. EMBO J (1986) 1.28
The upstream operator of the Escherichia coli galactose operon is sufficient for repression of transcription initiated at the cyclic AMP-stimulated promoter. EMBO J (1986) 1.27
Repression and catabolite gene activation in the araBAD operon. J Bacteriol (1987) 1.14
The interaction of L-arabinose and D-fucose with AraC protein. J Biol Chem (1974) 1.05
Mutations resulting in promoter-like sequences which enhance the expression of araC in Salmonella typhimurium. Gene (1986) 0.80
The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00
A concise guide to cDNA microarray analysis. Biotechniques (2000) 8.36
Positive control of enzyme synthesis by gene C in the L-arabinose system. J Bacteriol (1965) 6.59
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
ABC of medical computing. The Internet. BMJ (1995) 3.47
Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol (2000) 2.70
Lipoprotein from the outer membrane of Escherichia coli: purification, paracrystallization, and some properties of its free form. J Bacteriol (1976) 2.52
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31
Early events in RNA folding. Annu Rev Phys Chem (2001) 2.29
The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey. Eye (Lond) (2004) 2.23
Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. J Clin Microbiol (2001) 2.23
The organization of the araBAD operon of Escherichia coli. Gene (1986) 2.16
The araC gene of Escherichia coli: transcriptional and translational start-points and complete nucleotide sequence. Gene (1980) 2.11
Cryptococcosis in apparently immunocompetent patients. QJM (2006) 2.09
Direction of transcription of the regulatory gene araC in Escherichia coli B-r. Proc Natl Acad Sci U S A (1974) 2.05
Circumcision and breastfeeding. J Hum Lact (2000) 2.01
The Shatin community mental health survey in Hong Kong. II. Major findings. Arch Gen Psychiatry (1993) 1.99
ABC of medical computing. Computers in general practice--II. BMJ (1995) 1.97
The ldhA gene encoding the fermentative lactate dehydrogenase of Escherichia coli. Microbiology (1997) 1.96
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol (2001) 1.95
In vitro activation of the transcription of araBAD operon by araC activator. Proc Natl Acad Sci U S A (1974) 1.91
Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. Br J Addict (1992) 1.87
Purification and properties of an L-arabinose isomerase from Escherichia coli. J Biol Chem (1968) 1.86
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Outer membrane proteins of Escherichia coli: biosynthesis and assembly. FEBS Lett (1974) 1.70
Nucleotide sequence of the 5' end of araBAD operon messenger RNA in Escherichia coli B/r. Proc Natl Acad Sci U S A (1977) 1.69
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol (1998) 1.60
Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole. Antimicrob Agents Chemother (2000) 1.57
Amino acid replacement in a mutant lipoprotein of the Escherichia coli outer membrane. J Bacteriol (1977) 1.51
Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women. Fertil Steril (1998) 1.46
Typhlitis in patients with HIV-1 infection. Ann Intern Med (1992) 1.44
Crystalline L-ribulokinase from Escherichia coli. J Biol Chem (1967) 1.44
Golgi retention of a trans-Golgi membrane protein, galactosyltransferase, requires cysteine and histidine residues within the membrane-anchoring domain. Proc Natl Acad Sci U S A (1992) 1.43
Subunit structure of L-arabinose isomerase from Escherichia coli. J Biol Chem (1969) 1.42
Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence. Proc Natl Acad Sci U S A (1986) 1.42
Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol (2003) 1.41
Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol (2004) 1.39
Pseudomonas pseudomallei infection from drowning: the first reported case in Taiwan. J Clin Microbiol (1985) 1.39
Signaling via cAMP in fungi: interconnections with mitogen-activated protein kinase pathways. Arch Microbiol (1998) 1.38
Dynamic programming generation of boundaries of local coordinatized submanifolds in the neocortex: application to the planum temporale. Neuroimage (2003) 1.37
Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol (2001) 1.36
An analysis of some risk factors for lung cancer in Hong Kong. Int J Cancer (1985) 1.35
Chlamydial infections of the urethra in women. Genitourin Med (1985) 1.33
Persistence of chlamydial infection after treatment for neonatal conjunctivitis. Arch Dis Child (1981) 1.26
Spectral tuning in the human blue cone pigment. Biochemistry (1999) 1.23
Glutathione regulates interleukin-2 activity on cytotoxic T-cells. J Biol Chem (1989) 1.21
Stimulation of human leukocytes by protein II+ gonococci is mediated by lectin-like gonococcal components. Infect Immun (1985) 1.20
Periventricular and subcortical nodular heterotopia. A study of 33 patients. Brain (1995) 1.19
Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis (2008) 1.17
An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci (2001) 1.17
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia (2006) 1.16
Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging. Proc Natl Acad Sci U S A (2003) 1.16
Repression and catabolite gene activation in the araBAD operon. J Bacteriol (1987) 1.14
Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy. Neurology (1997) 1.12
Highly aligned epitaxial nanorods with a checkerboard pattern in oxide films. Nano Lett (2008) 1.12
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia (2012) 1.11
Expression of the Serratia marcescens lipoproteins gene in Escherichia coli. J Bacteriol (1981) 1.11
Direct observation of the proliferation of ferroelectric loop domains and vortex-antivortex pairs. Phys Rev Lett (2012) 1.09
Isolation of specialized transducing bacteriophage lambda carrying genes of the L-arabinose operon of Escherichia coli B/r. J Bacteriol (1975) 1.09
Crystalline L-ribulose 5-phosphate 4-epimerase from Escherichia coli. J Biol Chem (1968) 1.08
Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol (1997) 1.08
The poly-N-acetyllactosamines attached to lysosomal membrane glycoproteins are increased by the prolonged association with the Golgi complex. J Biol Chem (1991) 1.06
Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement. Mol Endocrinol (2001) 1.06
[Severe acute respiratory syndrome (SARS)]. Pneumologie (2003) 1.06
AraC proteins with altered DNA sequence specificity which activate a mutant promoter in Escherichia coli. J Biol Chem (1988) 1.04
Conduction of topologically protected charged ferroelectric domain walls. Phys Rev Lett (2012) 1.03
Clinical decision-making and mammography referral. Prev Med (1996) 1.03
Growth of Chlamydia trachomatis in Buffalo green monkey cells. Lancet (1982) 1.02
Fluconazole disk diffusion test with methylene blue- and glucose-enriched Mueller-Hinton agar for determining susceptibility of Candida species. J Clin Microbiol (2001) 1.02
Immunohistochemical localization of ciliary neurotrophic factor receptor alpha expression in the rat nervous system. J Neurosci (1996) 1.02
Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma. J Natl Cancer Inst (1978) 1.01
Exenatide efficacy and safety: a systematic review. Diabet Med (2009) 1.01
Lipid cell tumor of the ovary associated with endometrial adenocarcinoma--a case report. Changgeng Yi Xue Za Zhi (1989) 1.00
Synthesis and phosphodiesterase inhibitory activity of new sildenafil analogues containing a carboxylic acid group in the 5'-sulfonamide moiety of a phenyl ring. Bioorg Med Chem (2001) 0.98
Cross-control of magnetization and polarization by electric and magnetic fields with competing multiferroic and weak-ferromagnetic phases. Phys Rev Lett (2010) 0.97
Seizure outcome after temporal lobectomy for temporal lobe epilepsy: a Kaplan-Meier survival analysis. Neurology (2000) 0.97
External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme. Diabet Med (2012) 0.95
Rubella virus-induced apoptosis varies among cell lines and is modulated by Bcl-XL and caspase inhibitors. Virology (1999) 0.95
Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues. Bioorg Med Chem (2001) 0.95
Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax (2004) 0.95
Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia (1999) 0.93
Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives. Adv Prostaglandin Thromboxane Res (1980) 0.93
Evaluation of exposure to ethylene glycol monoethyl ether acetates and their possible haematological effects on shipyard painters. Occup Environ Med (1999) 0.93
Discovery of encysted Paragonimus westermani eggs in the omentum of an asymptomatic elderly woman. Am J Trop Med Hyg (1997) 0.93
Design, chemical synthesis, and expression of genes for the three human color vision pigments. Biochemistry (1991) 0.93
On the mechanism of the pentose phosphate epimerases. J Biol Chem (1972) 0.93
Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives containing an N-acylamido group phenyl ring. Bioorg Med Chem (2001) 0.92
Coordination of enzyme synthesis in the L-arabinose operon in Escherichia coli. I. The effect of manganous ion on the synthesis of L-arabinose isomerase. J Biol Chem (1971) 0.92
Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol (2014) 0.92
Cloning with tandem gene systems for high level gene expression. Nucleic Acids Res (1984) 0.91
Metabolism of D-arabinose by Escherichia coli B-r. J Bacteriol (1974) 0.90
Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids. J Natl Cancer Inst (1978) 0.90
Magnetic resonance imaging evidence of hippocampal sclerosis in progression: a case report. Epilepsia (1995) 0.90
Collective magnetism at multiferroic vortex domain walls. Nano Lett (2012) 0.90
A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med (1999) 0.89
Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome. Bone Marrow Transplant (2002) 0.89
Chronic ethanol administration decreases brain-derived neurotrophic factor gene expression in the rat hippocampus. Neurosci Lett (1995) 0.88